Mercurna is a Netherlands-based biotech startup developing messenger RNA (mRNA) based medicines. To that end we are continuously perfecting our platform technology which combines unique cell-targeting ligands, with a proprietary lipid-based delivery vehicle to deliver engineered mRNA with high efficiency and high specificity to the diseased tissues. We leverage this platform in our pursuit of various life-changing medicines. We are in particular determined to deliver first-of-its-kind precision medicines for inflammatory diseases, with a current focus on (chronic) kidney disease.
| Website | https://www.mercurna.com |
| Employees | 10 (4 on RocketReach) |
| Founded | 2017 |
| Address | Energieweg 46, Nijmegen, Gelderland 6541 CX, NL |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Biotechnology Research, Biopharma, Mrna Synthesis, Biotechnology, Mrna Therapeutics, Health Care, Chronic inflammatory disease, Science and Engineering |
| Keywords | Mrna Therapeutics, Messenger Rna, Rna Therapeutics, Drug Delivery, Rna Technology, Lipid Nanoparticles, Drug Discovery, Delivery Systems, Gene Therapy, Therapeutic Development, Platform Technology, Pharmaceutical Research, Molecular Medicine, Precision Medicine, Innovative Medicines, Biotechnology, Pharmaceutical |
| Competitors | GenScript, Mirus Bio, Thermo Fisher Scientific, QIAGEN, MilliporeSigma, Lonza, Promega Corporation, Bio-Rad Laboratories, Azenta Life Sciences +32 more (view full list) |
Looking for a particular Mercurna employee's phone or email?
Jenny der Wijst is the CEO of Mercurna.
4 people are employed at Mercurna.
Mercurna is based in Nijmegen, Gelderland.